Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...
What am I supposed to do when the best part of me was always you? And What am I supposed to say when I'm all choked up and you're okay? And what am I going to do when the best part of me was always ...
CRISPR ETFs invest in companies perfecting gene-editing technology, potentially key for future disease treatments. Top CRISPR ETFs include ARK Genomic Revolution, Global X Genomics, and WisdomTree ...
There was a mistake in the caption of Figure 1 as published. The legend of Figure 1 included text from an older version of the figure, which should have been removed. The incorrect caption read: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback